Post-marketing Safety Surveillance of the Injection of DanShenDuoFenSuanYan A Real World Study

NCT01872520 · clinicaltrials.gov ↗

COMPLETED

Status

30180

Enrollment

OTHER

Sponsor class

Conditions

Adverse Drug Reaction

Sponsor

Peking University Third Hospital

Collaborators

[object Object]
[object Object]